APBI 2016

Skin dose and skin volume definitions

Trial / author

Shah-ABS, Brachytherapy 2013;12:267–77. NSABP-39/RTOG-0413 GEC-ESTRO Phase III. Hilts, Brachytherapy 2015;14:970–8. Gifford, Brachytherapy 2013;12:114–9. Major, Radiother Oncol, Lettmaier, Radiother Oncol, 2011;100:189–94. Al-Rahbi, J Cancer Ther 2013;4:10–7.

d = 0, maximal surface dose

d = 2 mm

d = 5 mm

d = 8 mm

Khan, Brachytherapy 5:183-188. 2006